A Study of Lumateperone in Adolescent Subjects with Bipolar I & II Disorder

  • Ages 13-17
  • Diagnosis of or symptoms consistent with Bipolar I or II
  • Current depressive episode is between 4 weeks and 12 months in length
  • Has experienced at least 1 lifetime manic or hypomanic episode
  • If you have history of other psychiatric conditions or medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial
  • Method of Administration :  Oral / Capsule
    • Length/Duration: 6 weekly visits
    • Location:  721 North Magnolia Avenue, Orlando FL 32803
    • Compensation: TBD
    • Participants may:
      • See a doctor or medical staff at no cost
      • Have access to trial medications
      • Receive compensation for time and travel
  • This field is for validation purposes and should be left unchanged.